EntryPoint Capital, LLC AQST — AQUESTIVE THERAPEUTICS INC

Ownership history in EntryPoint Capital, LLC  ·  7 quarters on record

AI Ownership Summary

EntryPoint Capital, LLC reported AQUESTIVE THERAPEUTICS INC (AQST) in 7 quarterly 13F filings from 2024 Q3 through 2026 Q2. Peak portfolio weight reached 0.26% in 2025 Q1. The latest visible filing shows AQST at 0.11% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this AQST ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was EntryPoint Capital, LLC's position in AQUESTIVE THERAPEUTICS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

AQST was reported at 0.11% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.26% in 2025 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q3 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

AQST stock page EntryPoint Capital, LLC fund profile EntryPoint Capital, LLC full holdings
How EntryPoint Capital, LLC held AQST — position size vs. price
% of Fund (quarterly)    AQST price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 7 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 ADDED — — — 62,201 +33,456 +116.4% 0.11% $162K 2026-08-13 $4.25
2025 Q4 UNCHANGED — — — 28,745 — 0% 0.07% $186K 2026-02-12 $3.75
2025 Q3 REDUCED 80.7% +15.7% ❌ 28,745 -120,411 -80.7% 0.06% $161K 2025-11-13 $5.30
2025 Q2 REDUCED 22.6% +70.7% ❌ 149,156 -43,600 -22.6% 0.25% $494K 2025-08-11 $3.86
2025 Q1 ADDED — — — 192,756 +56,959 +41.9% 0.26% $559K 2025-05-14 $2.22
2024 Q4 ADDED — — — 135,797 +112,210 +475.7% 0.20% $483K 2025-02-11 $2.97
2024 Q3 INITIATED — — — 23,587 — — 0.07% $117K 2024-11-13 $4.83

🏢 Other funds also holding AQST

As of 2026 Q2 — sorted by position size

Bratton Capital Management, L.P. 3Y 7Y 100.0% Propel Bio Management, LLC 3.14% Everstar Asset Management, LLC 1.23% Sio Capital Management, LLC 3Y 7Y 1.02% Samsara BioCapital, LLC 3Y 7Y 0.85% Latash Investments, LLC 3Y 7Y 0.74% Blue Owl Capital Holdings LP 3Y 0.59% Pavaki Capital Management LLC 0.57% DAFNA Capital Management LLC 3Y 7Y 0.51% Rosalind Advisors, Inc. 0.39%

FAQ About EntryPoint Capital, LLC and AQST

These are the practical questions this page is built to answer before you even open the full history table.

How long has EntryPoint Capital, LLC reported owning AQST?

EntryPoint Capital, LLC reported AQST across 7 quarterly 13F filings, from 2024 Q3 through 2026 Q2.

What was the largest reported AQST position in EntryPoint Capital, LLC's portfolio?

The largest reported portfolio weight for AQST was 0.26% in 2025 Q1.

What is the latest reported AQST position on this page?

The most recent filing on this page is 2026 Q2, when EntryPoint Capital, LLC reported 62,201 shares, equal to 0.11% of portfolio, with an estimated market value of $162K.

What does the chart on this AQST ownership page compare?

The chart compares EntryPoint Capital, LLC's quarterly AQST portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did EntryPoint Capital, LLC time their AQST position?

Based on 13F filing dates vs. subsequent AQST price moves, EntryPoint Capital, LLC correctly timed 2 out of 5 reported position changes (40%). The annualised alpha on AQST relative to SPY over the holding period was -21.0%.

← Back to EntryPoint Capital, LLC Holdings